Dow Jones Newswires: AstraZeneca’s Forxiga gets EU approval recommendation for symptomatic chronic heart failure
The recommendation covers heart failure with reduced ejection fraction--a measure of the amount of blood the heart's left ventricle pumps with each heartbeat.